Regulation of Fas-dependent activation-induced T cell apoptosis by cAMP signaling: a potential role for transcription factor NF-kappa B

Oncogene
V N IvanovT R Malek

Abstract

TCR-mediated activation of T cell hybridomas induces programmed cell death by a Fas-dependent pathway. We now show that costimulation of 2B4 cells, in the absence or presence of transgenic Bcl-2, with anti-CD3 epsilon and forskolin, an activator of cAMP signaling, resulted in antagonism of Fas-dependent activation-induced cell death that was always accompanied by selective downregulation of the nuclear levels of NF-kappa B p65-p50 (RelA-p50) transcription factor. Forskolin not only inhibited activation-induced cell death and NF-kappa B activation, but also suppressed expression of Fas and Fas ligand (Fas-L). Furthermore, NF-kappa B p65 antisense oligonucleotide down-regulated nuclear levels of NF-kappa B, inhibited cell surface expression of Fas-L and apoptosis of 2B4. Collectively, these finding demonstrate a potential role of NF-kappa B in the regulation of activation-induced apoptosis in T lymphocytes.

Citations

Oct 3, 1999·European Journal of Immunology·S C HsuM Z Lai
Sep 11, 1999·Immunology Letters·L V VargaA Falus
Mar 30, 2002·Critical Reviews in Oncology/hematology·Fei Chen, Xianglin Shi
Oct 18, 2003·Seminars in Immunology·Min Li-Weber, Peter H Krammer
Aug 26, 2000·Cytokine & Growth Factor Reviews·A DenkB Baumann
Jan 5, 1999·The Journal of Experimental Medicine·T HettmannJ M Leiden
Feb 28, 2002·Annual Review of Immunology·Noah Isakov, Amnon Altman
Oct 17, 2002·Cell Stress & Chaperones·Charles Giardina, Andrea K Hubbard
Sep 10, 2013·Surgical Oncology Clinics of North America·Derek J Erstad, James C Cusack
Aug 13, 2009·International Immunopharmacology·Megumi GotoTakashi Nishimura
Mar 23, 2012·Immunological Reviews·Joseph A DiDonatoMichael Karin
May 20, 2003·Biochemical Pharmacology·Bruno NeuChristian Prinz
Aug 4, 2001·The American Journal of Pathology·F ChenX Shi
Jun 2, 2000·Gastroenterology·R M Schmid, G Adler
Mar 13, 1999·The Journal of Biological Chemistry·R F McClureC V Paya
Dec 22, 1999·Oncogene·M Barkett, T D Gilmore
Jun 6, 2003·Oncogene·Vladimir N IvanovZe'ev Ronai
Jun 22, 2017·Proceedings of the National Academy of Sciences of the United States of America·Michael-Claude G BeltejarJoseph A Beavo
Aug 28, 1999·The Journal of Biological Chemistry·S C HsuM Z Lai
May 9, 1998·The Journal of Biological Chemistry·M K BauerK Schulze-Osthoff
Oct 13, 2001·American Journal of Physiology. Lung Cellular and Molecular Physiology·T O Yarovinsky, G W Hunninghake
Feb 5, 2000·The Journal of Immunology : Official Journal of the American Association of Immunologists·J A Guevara PatiñoJ Nikolic-Zugić
Apr 22, 2005·The Journal of Immunology : Official Journal of the American Association of Immunologists·Karsten GülowPeter H Krammer
Nov 9, 2000·The Journal of Immunology : Official Journal of the American Association of Immunologists·J CaamañoC A Hunter
Mar 11, 2003·The Journal of Immunology : Official Journal of the American Association of Immunologists·Cristina M TatoChristopher A Hunter
Feb 15, 2000·International Reviews of Immunology·S T JuM Ozdemirli
Jan 5, 2000·Molecular and Cellular Endocrinology·F Delfino, W H Walker

❮ Previous
Next ❯

Related Concepts

Related Feeds

BCL-2 Family Proteins

BLC-2 family proteins are a group that share the same homologous BH domain. They play many different roles including pro-survival signals, mitochondria-mediated apoptosis and removal or damaged cells. They are often regulated by phosphorylation, affecting their catalytic activity. Here is the latest research on BCL-2 family proteins.

Antisense Oligonucleotides: ND

This feed focuses on antisense oligonucleotide therapies such as Inotersen, Nusinursen, and Patisiran, in neurodegenerative diseases including amyotrophic lateral sclerosis.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis